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ABSTRACT 
Spontaneous bacterial peritonitis is an acute bacterial infection of ascitic fluid; it has a 
high incidence in cirrhotic patients and it is associated with high mortality. In such a 
situation, early diagnosis and treatment is crucial for the survival of the patient. 
However, bacterial analysis in ascitic fluid is currently based on culture methods, which 
are time-consuming and laborious. We report here the application of a photonic 
interferometer biosensor based on a bimodal waveguide (BiMW) for the rapid and 
label-free detection of bacteria directly in ascitic fluid. The device consists of a straight 
waveguide in which two modes of the same polarization interfere while interacting with 
the external medium through their evanescent fields. A bimolecular event occurring on 
the sensor area of the device (e.g. capturing bacteria) will differently affect each light 
mode, inducing a variation in the phase of the light exiting at the output of the 
waveguide. In this work, we demonstrate the quantitative detection of Bacillus cereus in 
buffer medium and Escherichia coli in undiluted ascitic fluid from cirrhotic patients. In 
the case of Bacillus cereus detection, the device was able to detect bacteria in 15 min 
reaching limit of detections of 12 cfu∙mL-1 (cfu: colony forming unit) and in the case of 
Escherichia coli detection, the analysis time was 25 min obtaining a detection limit of 4 
cfu∙mL-1. Based on the results obtained, we consider that the BiMW biosensor is 
positioned as a promising new clinical tool for user-friendly, cost-effective and real-
time microbiological analysis. 
Keywords: Bimodal waveguide biosensor, label-free immunoassay, Bacillus cereus, 
Escherichia coli, ascitic fluid. 
 
Introduction 
A large proportion of cirrhotic patients has ascites (Fernández and Gustot 2012), i.e. an 
accumulation of fluid in the abdominal cavity. The infection of this ascitic fluid, called 
spontaneous bacterial peritonitis (SBP), is a common complication in these patients and 
the most frequent bacterial infection in cirrhosis. If this is not promptly diagnosed, the 
patient may develop multiorgan failure and severe infection in the blood. However, 
conventional clinical analysis of bacterial infections in ascites is based on cultures that 
are accurate methods but time-consuming and require highly skilled personnel. Several 
non-culture methods based on molecular techniques such as real-time PCR and 
microarrays have been developed. Although these techniques allow highly sensitive 
identification of bacteria and are faster than culture, they involve sample amplification 
and the use of fluorescence labels for the detection. These additional processes 
significantly increase the cost of the analysis and, as a consequence, molecular 
techniques cannot be extended to all pathogen detections performed in hospitals. Hence, 
culture methods still remain the gold standard for identifying bacteria in infected 
cirrhotic patients. 
So far, different label-free biosensing technologies have demonstrated their potential for 
fast and real-time microorganism diagnosis such the detection of Bacillus anthracis 
spores using a piezoelectric microcantilever sensor (McGovern et al. 2008), the 
detection of Escherichia coli using nonfaradic electrochemical impedance spectroscopy 
(Maalouf et al. 2007) and the detection of Salmonella Typhimurium by an automated 
quartz crystal microbalance (Salam et al. 2013). However, optical biosensors have 
attracted increasing attention in microbiological testing, since in addition to the label-
free detection, they can offer a highly sensitive analysis, miniaturization and cost-
effective production. The sensing principle that these devices employ is based on 
evanescent field detection; i.e. part of the light confined in a waveguide material can 
travel outside interacting with the external medium. Changes in the external refractive 
index affect (by its evanescent field) some property of the confined light (phase, 
intensity, wavelength…) that can be measured. Several evanescent wave biosensors 
have demonstrated their suitability for the label-free testing of bacteria. The detection of 
106 cfu∙mL-1 (cfu: colony forming unit) of Escherichia coli in buffer medium has been 
attained by an immunoassay using a surface plasmon resonance (SPR) biosensor. By 
implementing a sandwich assay, the SPR biosensor detected Escherichia coli 
concentrations 3 orders of magnitude lower than by a direct assay (Subramanian et al. 
2006).  Recently, the detection of Escherichia coli at a concentration of 50 cfu∙mL-1 has 
been achieved by combining spectroscopy of grating-coupled long-range surface 
plasmons (LRSPs) with a magnetic nanoparticle (MNP) assay (Wang et al. 2012). SPR 
biosensors employing bacteriophages probes, instead of antibodies as bioreceptors, can 
achieve limits of detections of 102-103 cfu∙mL-1 in buffer medium (Arya et al. 2011; 
Balasubramanian et al. 2007). Fiber optic biosensors have been also reported for 
detection of Salmonella, obtaining detection limits of 103 cfu∙mL-1 in buffer medium 
and 104 cfu∙mL-1 in real food samples (Valadez et al. 2009). In a following work, the 
same sensor was multiplexed to detect simultaneously three pathogens (Listeria 
moncytogenes, Escherichia coli and Salmonella enterica) at concentrations of 103 
cfu∙mL-1 by later reaction with labeled antibodies (Ohk and Bhunia 2013). By 
employing a complete label-free scheme, concentrations as low as 5 ×104 cfu∙mL-1 of 
Escherichia coli were detected using transmitted laser intensity by capturing the 
bacteria on a glass modified with antibodies (Acharya et al. 2006) and Bacillus subtilis 
was detected at a concentration of 8 ×104 cfu∙mL-1 employing a leaky waveguide sensor 
devices (LWD) (Zourob et al. 2005). Although it has been demonstrated that optical 
biosensors provide rapid identification of bacteria, pre-enrichment of the sample or 
amplification of the signal are mandatory to achieve detections at relevant physiological 
levels (from 101 to 104 cfu∙mL-1). Therefore, there is an urgent unmet medical need for 
new label-free detection systems able to detect low bacteria concentrations in complex 
samples without the requirement of previous pretreatments. 
With this in mind, we developed a highly sensitive immunosensor based on the Bimodal 
Waveguide (BiMW) device for the direct and label-free identification of bacteria in 
ascitic fluid of cirrhotic patients. In this sensor, light is confined in a silicon nitride 
(Si3N4) waveguide covered with silicon oxide (SiO2) as cladding (see Fig. 1a). Initially, 
light is coupled in a single mode waveguide propagating the fundamental mode. After 
some distance, it is coupled in another waveguide supporting two-modes; the 
fundamental and the first mode. Then, both modes interfere and propagate until they 
exit the output of the waveguide. By opening the cladding at the bimodal part, the 
waveguide is exposed to the external medium, the sensor area of the device, where the 
bioreceptors (antibodies) are immobilized by covalent coupling. When the surface 
refractive index changes (e.g. by capturing a bacterium), both modes are differently 
affected through their evanescent fields which induces a phase variation in the light 
output. It is relevant to stress that the waveguide used in our study had highly reduced 
dimensions (see Fig. 1b); it consisted of a rib 4 µm wide and 1.5 nm high. The chips (30 
mm length and 10 mm width as shown in Fig. 1c) were fabricated using silicon standard 
microfabrication techniques which significantly reduce the cost per sensor. Another key 
point in our design is that the output signal is not sensitive to fluctuations in the 
coupling efficiency; it is not affected by either the thermal expansion of the mechanical 
holder or the fluctuations in the input light. It is achieved by normalizing the signal (S), 
proportional to the phase variations (Δφ (t)), with the total intensity (Iup + Idown) (see 




 𝛼 cos (𝛥𝜑(𝑡))                                                                (1) 
We have calibrated previously the BiMW detection limit for changes in the bulk 
refractive index obtaining a value of 2.5×10-7 RIU (Refractive Index Units) 
corresponding to a minimum change of Neff of 2.1×10-8 which position the BiMW 
transducer as one of the most sensitive label-free optical sensors (Zinoviev et al. 2011). 
 Fig. 1 (a) Sensing principle of a bimodal waveguide biosensor, the electromagnetic field associated with 
the light beam propagates through the waveguide, (b) AFM image of a rib waveguide of 1.5 nm height, 
(c) photo of a chip containing 16 BiMW interferometers and (d) processing of the signal, output light is 
distributed among up and down sections of the two-section photodetector.  
 
To evaluate the potential of the BiMW biosensor for rapid and early detection of 
bacterial infections in ascitic liquid, we developed an immunoassay in which specific 
antibodies were immobilized on the sensor area of the device. The first step in this work 
was the initial evaluation of the biosensor sensitivity for microorganisms by the 
detection of the non-pathogen Bacillus cereus (B. cereus) in buffer medium as a proof-
of-concept. The second step was to check if the sample manipulation influenced in the 
bacteria breaking. We also investigated if the breaking of the bacteria could enhance the 
sensitivity of the biosensor; samples were mechanically broken and the detection was 
compared with the one from unbroken bacteria. The last step was the evaluation of the 
BiMW biosensor for bacterial detection in pure ascitic fluids. For this, we employed 
Escherichia coli (E. coli) in real ascites samples, as this is of the most common bacteria 
related to ascitic infections. To our knowledge, this is the first label-free biosensor for 
bacterial detection operating in real ascitic fluids.   
Materials and methods  
Materials   
Lyophilized bacterial pellets of E. coli (ATCC 8739) and B. cereus (ATCC11778) were 
provided by ielab (Spain). Polyclonal antibodies were purchased from abcam® (Spain). 
Solvents for the device cleaning process: dry toluene, acetone, ethanol, hydrochloric 
acid (HCl, 35-38%), and methanol (MeOH) were supplied by Panreac (Spain). 
Carboxyethysilanetriol sodium salt (CTES) was purchased from ABCR (Germany). (3-
Aminopropyl)triethoxysilane (APTES), p-phenylenediisothiocynate (PDITC), N,N-
Dimethylformamide (DMF), pyridine, 1-ethyl-3(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC), N-hydroxysuccinimide (NHS) and the components for phosphate 
buffer saline tween (PBST; 10 mM phosphate, 2.9 mM KCl, 137 mM NaCl, 0.005% 
tween-20, pH 7.4),  2-N-morpholino ethanesulfonic acid (0.1 M MES, 0.5 M NaCl, pH 
5.5-6), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (10 mM HEPES pH  7.4) 
and carbonate buffer (0.1 M Na2CO3, pH 9) were purchased from Sigma-Aldrich 
(Spain). Copolymer poly-(L-lysine) graft-PEG (PLL-PEG, MW 75.000 g.mol-1) was 
purchased from SuSoS (Switzerland), nylon membrane filter was purchase from VWR 
international (USA) and Polydimethylsiloxane (PDMS) was purchased from Sylgard® 
(USA). Milli-Q water from Millipore (USA) was always employed. 
Bacteria purification 
The bacterial pellets were reconstituted in water employing the volume indicated by the 
manufacturer. Therefore, the concentration of the stock solutions was 7.41×105 cfu∙mL-1 
for B. cereus and 4.31×104 cfu∙mL-1 for E. coli. It is relevant to note that the values for 
bacteria concentration were certificated by different accredited laboratories conforming 
to internationally recognized standards. The bacterial solutions were aliquoted and 
stored at -20 °C until use. Purification of bacteria was carried out by centrifugation at 
3000 rpm for 15 min at 4º C. The supernatant was removed and the pellet was 
suspended in PBST for B. cereus and in ascitic fluid for E. coli. Each bacterial 
suspension was then mixed thoroughly using a pipette. Different concentrations of 
bacteria were prepared by diluting the stock solutions with the appropriate medium. For 
B. cereus, one mL of the stock solution was filtered with 0.2 µm nylon membrane filter. 
The filtered buffer was evaluated employing a nanophotometer from bioNovacientífica, 
s.l. (Spain) at 280 nm. 
Ascitic fluid samples 
The ascitic fluid sample from the therapeutic paracentesis of a cirrhotic patient was 
provided and characterized by the Medicine Liver Unit, Hospital Vall d’Hebron 
(Barcelona, Spain). The ascitic fluid employed in this work contained a protein 
concentration of 1.9 g∙dL-1, 135 UI∙L-1 concentration of lactate dehydrogenase, 0.13 × 
109 cells∙L-1 of total cells and 1 × 106 cells∙L-1 of red blood cells. The microbiological 
culture was negative. Sample was obtained after the patient had provided his/her 
informed consent and with the approval of the relevant Ethics Committee. 
Lysis of bacteria  
Different concentrations of bacterial solutions were lysed by thermal treatment (15 min 
at 100° C) and 50 min of sonication with an ultrasonic bath FB15054 (Fisher Scientific, 
Spain). Optical density of the solutions was measured using the nanophotometer at 600 
nm before and after the lysis treatment.  
Surface functionalisation and immobilisation of antibodies 
The chips were cleaned with acetone, ethanol and water, followed by sonication in 
methanol/hydrochloric acid 1:1 for 10 min, rinsing with water and drying with a stream 
of nitrogen. The oxidation was carried out using UV/O3 cleaner (BioForce 
Nanosciences, USA) for 1 h. Then the chips were immersed in a 10% HNO3 solution at 
75° C. Here, different functionalisations were carried out depending on the sample 
matrix: 
Detection of B. cereus in buffer medium (CTES functionalisation): The chip was 
functionalizated with CTES silane, following the protocol detailed by González-
Guerrero et al. (González-Guerrero et al. 2013). The silane coated chip was placed on 
the experimental set-up and the next steps were done in-situ employing water as running 
buffer at a flow rate of 20 µL∙min-1. The carboxylic groups on the sensor surface were 
activated by injecting a solution of 0.2 M EDC/0.05 M NHS in MES buffer. A 
polyclonal anti-B.Cereus/subtilis antibody solution in 10 mM PBST at a concentration 
of 50 µg∙mL-1 was immediately injected over the freshly activated surface. Finally, the 
surface was blocked using PLL-PEG at a concentration of 0.5 mg∙mL-1 in HEPES buffer 
to avoid non-specific adsorptions. 
Detection of E. coli in ascitic fluid (APTES functionalisation): The chip was incubated 
with 1% APTES silane solution in ethanol for 1h. It was then rinsed with ethanol and 
dried with a nitrogen stream. The chip was cured in an oven for 1 h at 110º C and 
activated with PDITC 20 mM in 10% of pyridine and DMF in dark for two hours. After 
incubation, the chip was washed with DMF and ethanol and dried with nitrogen. To 
incorporate the antibody, the sensor chip was immersed in a 50 μg∙mL-1 of anti-E.coli 
solution in carbonate buffer and allowed to react overnight in the dark and at room 
temperature. The chip was then washed with PBST and water, dried with nitrogen and 
placed on the set-up. PBST was employed as running buffer at a constant flow rate of 
20 µL∙min-1 and the surface was blocked by injecting PLL-PEG at 0.5 mg∙mL-1 in 
HEPES buffer. 
Optical bimodal waveguide sensor and experimental set-up 
Bimodal waveguide devices were designed and fabricated as previously described 
(Zinoviev et al. 2011). For optical evaluation, a He/Ne laser (λ= 632.8 nm) on TE 
polarization was used as a light source. Light was coupled into the waveguide using a 
40x microscope objective. For sensing, a 4-channel flow cell was fabricated using 
PDMS with an internal channel volume of 15 µl; each channel was 1 mm wide and 500 
µm high and covered four BiMW sensors. The solutions were flowed using a syringe 
pump and a circulation loop of 250 µL and a flow rate of between 5-40 µL∙min-1. The 
intrinsic sensitivity of the BiMW device to the temperature changes was compensated 
by incorporating a temperature controller providing a temperature stabilization of the 
chip with an accuracy of 0.01 degrees. Data acquisition and analysis was performed 
using LabVIEW (National Instruments, USA) software. 
Immunoassay 
During all the measurements, PBST was flowed over the sensor surface at a constant 
flow rate of 20 µL∙min-1 until a stable baseline was reached. Bacterial samples were 
introduced into a 250 µL loop and flowed over the sensor surface from low to high 
concentrations. After each measurement, HCl (100 mM) was employed to break the 
bacteria-antibody interaction at 30 µL∙min-1 in order to reuse the biosensor. 
For a clearer representation of the data, calibration curves are presented as phase 
variation vs. logarithmic value of bacteria concentration. Binding of bacteria to the 
antibodies immobilized on the sensor surface was performed in triplicate. The standard 
deviations from the mean value were calculated and the error bars estimated for each 
measurement. The theoretical limit of detection (LOD) was calculated from the linear 
regression of the linear part of the representation of phase variation vs bacteria 
concentration. LOD was established as the lowest bacterial concentration that could 
provide a phase variation signal at least three standard deviations greater than a signal 
from a negative control.  
 
Results and discussion 
Detection of B. cereus in buffer 
The BiMW sensor was biofunctionalised employing the silane CTES, providing the 
surface with a stable layer of carboxylic groups (González-Guerrero et al. 2013). In this 
way, it was possible to biofunctionalise the sensors located in one of the channels of our 
4-channel fluidic cell without altering the rest of the sensor devices. The remaining 
silanised sensors could be used later (even 1 month later) since they were located in 
independent fluidic channels. The silanised sensor chip was then placed on the 
experimental set-up where the activation of the carboxylic groups and subsequent amide 
biofunctionalisation were carried out in-flow as previously explained.  
A non-pathogenic bacterium (B. cereus) was employed as a model system for the 
evaluation of the biosensor performance in buffer medium. B. cereus is a large (1 × 3-4 
µm), gram-positive and rod-shape bacterium widely distributed in nature (Vilain et al. 
2006). Suspensions of B. cereus ranging from 70 to 7 × 105 cfu∙mL-1 were prepared in 
triplicate in PBST and were sequentially flowed through the sensor. Fig. 2a shows the 
calibration curve corresponding to triplicate measurements for each logarithmic 
concentration. The lowest concentration of B. cereus detected was 70 cfu∙mL-1 which 
produced a phase variation of 0.031 × 2π rad. The highest concentration detected was 7 
× 105 cfu∙mL-1 obtaining a phase variation of 1.13 × 2π rad. The specificity of the 
detection was evaluated by flowing a non-specific bacterium (E. Coli) at concentrations 
of 1×103 and 1×104 cfu∙mL-1. No significant binding was observed for any 
concentration, confirming that the signal contribution had come only from specific 
detection of B. cereus bacteria. The theoretical LOD for B. cereus detection was 
calculated from the linear fitting of the representation of the phase variation vs. bacteria 
concentration (inset of Fig. 2a) obtaining a value of 12 cfu∙mL-1.   
The pretreatment employed for purification of bacteria (ultracentrifugation and mixing 
process) could have broken the bacteria and liberated antigens from the bacteria 
membrane that would have erroneously enhance the sensor signal. In order to check the 
contribution of this effect, different B. Cereus concentrations ranging from 70 to 7×105 
cfu∙mL-1 were filtered and each filtered buffer was sequentially injected into the sensor. 
In Fig. 2a, it can be observed that the filtered bacterial solutions gave a negligible 
signal. The results were confirmed by the nanophotometer (operating at 280 nm) in 
which absorbance of these solutions was negligible indicating that the buffer was free of 
proteins. These experiments validated our procedure for sample preparation, ensuring 
that we have only entire bacteria after the purification process.  
Representative signals of specific B. cereus detection (7×103 cfu∙mL-1), non-specific E. 
coli (1×104 cfu∙mL-1) and filtered buffer of a B. cereus solution (7×103 cfu∙mL-1) are 
shown in Fig. 2b. These signals show a phase variation of 0.27 × 2π rad for the 
detection of 7×103 cfu∙mL-1 of B. cereus and a negligible phase variation for the 
detection of 1×104 cfu∙mL-1 of E. coli, which indicated the specificity of the 
immunoassay.
 
Fig. 2 (a) Calibration curve for the detection of triplicate logarithmic concentrations of B. cereus bacteria 
(black, squares) ranging from 70 to 7×105 cfu∙mL-1 [the exponential fit equation is given by y = 1.05 – 
0.99∙e(-4.13×10^-6 x)] in comparison with non-specific bacteria E. Coli (red, circles) at concentrations of 
1×103 cfu∙mL-1 and 1×104 cfu∙mL-1 and concentrations of filtered buffer from B. Cereus solutions (blue, 
triangles) ranging from 70 to 7×105 cfu∙mL-1. In the inset: linear representation of the data for the B. 
Cereus detection [linear regression of the linear part is given by y = 2.18 ∙ 10-5 x + 0.031, r2 = 0.94521] 
and (b) real-time detection of specific B. cereus solution at a concentration of 7×103 cfu∙mL-1 (black line), 
non-specific E. coli solution at a concentration of 1×104 cfu∙mL-1 (red line) and filtered buffer from B. 
cereus solution at a concentration of 7×103 cfu∙mL-1 (blue line) by a direct immunoassay in PBST buffer. 
 
Regeneration cycles (i.e. removal with acid conditions) are commonly employed to 
reuse the sensor surface in case this might be necessary, either to lengthen the surface 
life-time, to save costs or to study the reproducibility and optimization of the 
immunoassay protocols. In our study, after trying different regeneration solutions, the 
complete removal of the target bacteria was achieved by flowing HCl 100 mM without 
altering the amount of antibody on the surface. As can be seen in Fig. 3a, after a 
regeneration step, the baseline for B. cereus, which had been previously detected at a 
concentration of 7×104 cfu∙mL-1, was recovered. Under these conditions, stability of the 
bioreceptor layer was maintained up to 6 cycles due to the limited stability of antibodies 
after aggressive acid medium treatments. Fig. 3b shows the triplicate measurements for 
the concentrations of 7×102 and 7×103 cfu∙mL-1 of B. cereus. 
 
Fig. 3 (a) Real-time evaluation of a concentration of 7×104 cfu∙mL-1 of B. cereus, followed by 
regeneration using HCl 100 mM. The dash lines indicate the recovering of the baseline after the 
regeneration and (b) real-time triplicate measurements of 7×102 and 7×103 cfu∙mL-1 of B. cereus.  
As explained above, the fragmentation of the bacteria can enhance the signal for a 
determined concentration since dispersion of the bacterial membrane along the medium 
increases the probability of capturing the antigen targets. We investigated the increase 
of the sensitivity when bacterial samples were mechanically lysed before injecting in the 
biosensor. The lysis of the bacteria was confirmed by evaluating the optical density of 
the bacterial solutions. The value obtained for non-treated samples at a concentration of 
7 × 105 cfu∙mL-1 was 0.704, whereas for a lysed bacterial sample of the same 
concentration the value was 0.221, indicating that the major part of the bacteria in the 
sample was fragmented. The calibration curve for logarithmic concentrations of lysed 
bacteria in comparison to the one for whole bacteria is shown in Fig. 4a. It can be 
calculated that the sensitivity (in terms of discrimination between different 
concentrations) is 6% higher for lysed bacteria than for whole bacteria. Fig. 4b, shows a 
comparison of real-time signals for the concentrations of 7×102 and 7×103 cfu∙mL-1 for 
lysed and whole bacteria. The increase in the signal due to the lysis pretreatment was 
around 35% and 30% for 7×102 and 7×103 cfu∙mL-1, respectively. It is worth mentioning 
that the sonication treatment is time-consuming, thus the advantages in the increase of 
the signal must be significant (more than 100%) in order to consider its implementation 
in this type of analysis. From these findings, it can be concluded that the increase of the 
signals obtained by sonicating the samples did not justify the incorporation of a 
pretreatment step which could have delayed the result of the analysis by more than one 
hour.  
 
Fig. 4 (a) Calibration curves for the logarithmic concentration of lysed B. cereus solutions ranging from 
7×102 to 7×105 cfu∙mL-1 in PBST buffer [the exponential fit equation is given by y = 1.06 – 0.90∙e(-4.8×10^-6 
x)] in comparison with the same concentration solutions of whole bacteria [the exponential fit equation is 
given by y = 1.0 – 0.99∙e(-4.3×10^-6 x)]. In the inset: linear representation of the data for lysed B. Cereus 
detection [linear regression of the linear part is given by y = 3.8 ∙ 10-6 x + 0.15, r2 = 0.998] and for whole 
B. Cereus detection [linear regression of the linear part is given by y = 3.6 ∙ 10-6 x + 0.05, r2 = 0.953] and 
(b) real-time signals for whole and lysed bacteria in buffer solution for 7×102 and 7×103 cfu∙mL-1. 
 
Detection of E. coli in ascitic fluid 
The following stage of this study concerned the direct and label-free bacterial detection 
in 100% human ascitic fluid using the BiMW biosensor. As previously described, this 
analysis can become especially complex due to interferences and undesired non-specific 
adsorption of matrix components present in the ascitic fluid. In the case of a label-free 
detection and, in particular, in evanescent wave-based biosensors, where signals are 
directly related with mass changes on the sensor surface, this must be fully minimized. 
As listed above, the ascitic fluid employed in this work contained concentrations of 
proteins in the same range (20 mg∙mL-1) as serum or plasma (60-80 mg∙mL-1). In 
addition, the high cell content of ascitic fluid (1.3 × 105 cell∙mL-1) represented another 
source of potential non-specific adsorptions. Therefore, it is clear that the detection of 
bacteria in undiluted ascitic fluid samples is a new and complex challenge for optical 
label-free immunosensors.  
The method employed to functionalise the surface must assure a good coverage and 
non-fouling properties. We employed an APTES functionalisation for immobilizing the 
bioreceptors in the case of detection in ascitic fluid since previous experiments (not 
shown) demonstrated better non-fouling properties for complex matrixes than the CTES 
silanisation. This effect has been mainly attributed to the formation of compact 
monolayers by π-π stacking of the PDITC linker (Gandhiraman et al. 2010). 
Additionally, we employed a solution of PLL-PEG to block the sensor surface before 
the immunoassay. This methodology for reducing non-specific binding when evaluating 
real samples has been previously optimised and validated (Soler et al. 2014).  
For the detection of bacterial infections in ascitic fluid, we selected E. coli since it is 
highly common in SBP and it is related to nosocomial infections in hospitals. E. coli has 
a size of 2 µm in length and 0.5-1 µm in width and it is a gram-negative, facultative 
anaerobic and rod-shaped bacterium. To detect E. coli using the BiMW biosensor, 
solutions ranging from 40 cfu∙mL-1 to 4 × 104 cfu∙mL-1 were prepared in triplicate by 
spiking the ascitic fluid with different amounts of the stock solution. PBST was 
employed as running buffer and different concentrations of spiked ascitic fluid were 
flowed through the channel of the biosensor. The sensor surface was then regenerated 
by injecting HCl 100 mM. Assays with PBST as running buffer resulted in good 
repeatability until the seventh cycle.  
The calibration curve for triplicate measurements of each logarithmic concentration is 
shown in Fig. 5. The phase variation for the highest concentration evaluated (4 × 104 
cfu∙mL-1) was 2.5 × 2π rad and for the lowest concentration (40 cfu∙mL-1) was 0.21 × 2π 
rad. LOD calculated from the fitting of the linear representation of E. coli detection (in 
the inset) was 4 cfu∙mL-1. To evaluate the contribution of the sample matrix to the 
signal, pure ascitic fluid was injected into the biosensor. Injection of undiluted ascitic 
fluid in triplicate resulted in small and constant background signals due to the matrix 
(0.10, 0.15 and 0.13 × 2π rad). After each evaluation of the ascitic fluid non-specific 
adsorption, bioreceptor surface was cleaned by injecting the regeneration solution 
before a new injection. Fig. 5, shows the specific calibration curve compared to the 
average of the phase variation (0.13 ± 0.02 × 2π rad) obtained for the pure ascitic fluid 
detection. As can be observed, the signal due to the non-specific adsorption of the 
ascitic fluid matrix was negligible when comparing with the specific E. coli signal. 
 
 
Fig. 5 Calibration curve for triplicate spiked concentrations of E. coli ranging from 40 and 4 ×104 cfu∙mL-
1 in ascitic fluid (black, squares) [the exponential fit equation is given by y = 12.5 – 12.2 ∙ e (-5.3×10^-6 x)] 
and unspecific detection of pure ascitic fluid. In the inset: linear representation of the data for E. Coli 
detection [the linear regression is given by y = 5.7∙10-5 x + 0.3, r2 = 0.982]. 
Fig. 6a shows a representative real-time signal for the detection of a spiked 
concentration of E. coli of 4 ×103 cfu∙mL-1 in human ascitic fluid. The real-time 
measurement of pure ascitic fluid is shown in Fig. 6b. An increase of the resulting phase 
variation for the E. coli spiked sample can be observed, indicating specific detection of 
the bacteria.  
 
Fig. 6 Real-time measurements of ascitic fluid (a) spiked with E. coli at a concentration of 4 ×103 cfu∙mL-
1and (b) pure ascitic fluid. 
In this work we have demonstrated that the BiMW biosensor can detect extremely low 
bacterial concentration in a label-free and fast way. The superior sensitivity of the 
BiMW device when comparing with other label-free biosensors can be attributed to the 
large effective sensing area (15000 μm long) which increases the probabilities to bind 
the microorganisms. It must be highlighted that, despite the high content of proteins and 
cells in the ascitic fluid, exceptional LOD was obtained for the detection of harmful 
bacteria which indicates, not only a highly sensitive transducer but an intensive effort in 
developing the appropriate biofunctionalization technique for each particular 
application. 
Conclusions 
We present here the development of a BiMW biosensor for rapid and label-free 
detection of spontaneous bacterial peritonitis. Our results show that the BiMW 
biosensor was capable of detecting E. coli at a concentration as low as 40 cfu∙mL-1 
employing a label-free direct immunoassay in real ascitic fluid obtaining a LOD of 4 
cfu∙mL-1. Furthermore, each detection was performed in 15 minutes, without the need of 
any purification pretreatment or specially trained personnel.  
It must be noted that the investigation of the cross-reactivity of the antibodies employed 
for E. coli with other common bacteria in SBP was not the aim of the present work. 
However, the study of the employed antibodies and their unspecific interactions with 
other bacteria present in human ascetic fluid is the next step in the development of the 
presented biosensor. The variability in the content and composition (salt, pH and cells) 
of ascitic liquid from different patients could affect the result of the immunoassay 
indicating the need for future studies on how variations in ascitic liquids from different 
patients influence bacterial immunodetection. Finally, despite the detection of very low 
bacterial concentrations is not a requirement for the selected bioapplication, it is clear 
that a proper microfluidic design is a key factor to enhance the probability of 
microorganism binding to the biofunctionalised sensor surface and work is in progress 
to incorporate a more advanced microfluidic cell.  
As conclusion, the results presented in this work show the great potential of the BiMW 
technology for the label-free and cost-effective identification of the most frequent 
bacteria present in ascitic fluid. Moreover, this technology could be easily used in 
clinical settings to facilitate early bacterial diagnostics thereby improving patient 
prognosis and reducing the costs associated with medical complications in hospitalized 
patients. 
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